Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock $0.0001 par value per share
-
Shares outstanding
-
27,725,634
-
Total 13F shares
-
31,808,667
-
Share change
-
-141,953
-
Total reported value
-
$97,015,342
-
Put/Call ratio
-
70%
-
Price per share
-
$3.05
-
Number of holders
-
100
-
Value change
-
-$20,514,565
-
Number of buys
-
51
-
Number of sells
-
71
Institutional Holders of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) as of Q2 2024
As of 30 Jun 2024,
RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,808,667 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, Column Group LLC, BlackRock Inc., KINGDON CAPITAL MANAGEMENT, L.L.C., MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, D. E. Shaw & Co., Inc., and FEDERATED HERMES, INC..
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.